Dr. Whitman on Eliminating Financial Toxicity in Oncology

Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses eliminating financial toxicity in oncology.

The goal of being an oncologist is to provide the best cancer care to patients, explains Whitman. That includes access to the newest therapies and the newest technologies. In addition to these facets of cancer care, Whitman explains that the last variable is affordability.

On October 4 2018, Atlantic Health System announced The Breakthrough Oncology Accelerator flagship program, in which Atlantic Health will partner with the Translational Genomics Research Institute (TGen) and Origin Commercial Ventures to develop a new platform to ensure economically accessible immunotherapies and other prominent cancer therapies to the region. It is through Atlantic Health System’s partnership with Origin and TGen that they hope to bridge this gap in accessibility and increase the rate of cure, says Whitman.